- Home
- EVOK vs ONFO Comparison
EVOK vs ONFO Comparison
Compare EVOK & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- ONFO
- Stock Information
- Founded
- EVOK 2007
- ONFO 2018
- Country
- EVOK United States
- ONFO United States
- Employees
- EVOK N/A
- ONFO N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- EVOK Health Care
- ONFO Technology
- Exchange
- EVOK Nasdaq
- ONFO Nasdaq
- Market Cap
- EVOK 5.4M
- ONFO 5.2M
- IPO Year
- EVOK 2013
- ONFO 2022
- Fundamental
- Price
- EVOK $5.21
- ONFO $1.02
- Analyst Decision
- EVOK
- ONFO
- Analyst Count
- EVOK 0
- ONFO 0
- Target Price
- EVOK N/A
- ONFO N/A
- AVG Volume (30 Days)
- EVOK 437.4K
- ONFO 26.1K
- Earning Date
- EVOK 11-06-2025
- ONFO 08-14-2025
- Dividend Yield
- EVOK N/A
- ONFO N/A
- EPS Growth
- EVOK N/A
- ONFO N/A
- EPS
- EVOK N/A
- ONFO N/A
- Revenue
- EVOK $12,794,859.00
- ONFO $10,508,728.00
- Revenue This Year
- EVOK $57.38
- ONFO N/A
- Revenue Next Year
- EVOK $59.57
- ONFO N/A
- P/E Ratio
- EVOK N/A
- ONFO N/A
- Revenue Growth
- EVOK 70.02
- ONFO 78.36
- 52 Week Low
- EVOK $1.94
- ONFO $0.61
- 52 Week High
- EVOK $12.32
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- EVOK 50.12
- ONFO 46.27
- Support Level
- EVOK $5.03
- ONFO $0.93
- Resistance Level
- EVOK $5.57
- ONFO $1.03
- Average True Range (ATR)
- EVOK 0.44
- ONFO 0.06
- MACD
- EVOK -0.09
- ONFO -0.00
- Stochastic Oscillator
- EVOK 11.17
- ONFO 52.94
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.